MARKET

AMED

AMED

Amedisys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

241.25
+4.63
+1.96%
After Hours: 241.25 0 0.00% 16:42 03/05 EST
OPEN
236.10
PREV CLOSE
236.62
HIGH
242.32
LOW
226.05
VOLUME
319.24K
TURNOVER
--
52 WEEK HIGH
325.12
52 WEEK LOW
132.95
MARKET CAP
7.92B
P/E (TTM)
43.71
1D
5D
1M
3M
1Y
5Y
Independent Director Bruce Perkins Just Bought 3.7% More Shares In Amedisys, Inc. (NASDAQ:AMED)
Investors who take an interest in Amedisys, Inc. ( NASDAQ:AMED ) should definitely note that the Independent Director...
Simply Wall St. · 1d ago
How to Develop Trading Plans for Amedisys $AMED and other Stocks
Mar 05, 2021 (Stock Traders Daily via COMTEX) -- According to Stock Traders Daily, a 2-year industry veteran, investors can use the price action in Amedisys...
Stock Traders Daily · 2d ago
Global Elderly Care Service Market Outlook, Industry Analysis and Prospect 2019-2025
Mar 03, 2021 (Heraldkeepers) -- COMTEX_382079800/2582/2021-03-03T13:06:40 Is there a problem with this press release? Contact the source provider Comtex at...
Heraldkeepers · 4d ago
Amedisys to Present at Two Virtual Investor Conferences
BATON ROUGE, La., March 01, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Chief Executive Officer, will present at both the 42nd Ann...
GlobeNewswire · 5d ago
Death Care Market Size 2021,Industry Analysis, Size, Share, Trends, Market Demand, Growth, Opportunities and Forecast 2026
Mar 01, 2021 (The Expresswire) -- In 2021 ,Death Care Market “ Death care includes companies who provide death-related goods and services such as funerals,...
The Express Wire · 6d ago
--Analyst Actions: RBC Capital Adjusts Amedisys' Price Target to $335 From $333, Maintains Outperform Rating
MT Newswires · 02/26 08:23
DJ Amedisys, Inc. CEO Paul Kusserow on Q4 2020 Results -- Earnings Call Transcript >AMED
Dow Jones · 02/26 05:26
Amedisys (AMED) Q4 Earnings Beat Estimates, Revenues Miss
Zacks.com · 02/25 15:35
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMED. Analyze the recent business situations of Amedisys through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AMED stock price target is 323.77 with a high estimate of 340.00 and a low estimate of 261.00.
EPS
Institutional Holdings
Institutions: 586
Institutional Holdings: 31.97M
% Owned: 97.31%
Shares Outstanding: 32.85M
TypeInstitutionsShares
Increased
145
1.72M
New
92
-126.07K
Decreased
147
1.61M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+1.72%
Healthcare Providers & Services
+2.82%
Key Executives
Chairman/Chief Executive Officer/Director
Paul Kusserow
President/Chief Operating Officer
Christopher Gerard
Chief Financial Officer/Executive Vice President
Scott Ginn
Chief Human Resource Officer
Sharon Brunecz
Chief Information Officer
Michael North
Chief Compliance Officer
Denise Bohnert
Other
David Kemmerly
Lead Director/Independent Director
Richard Lechleiter
Director
Ivanetta Samuels
Independent Director
Vickie Capps
Independent Director
Molly Coye
Independent Director
Julie Klapstein
Independent Director
Teresa Kline
Independent Director
Bruce Perkins
Independent Director
Jeffrey Rideout
No Data
About AMED
Amedisys, Inc. is a healthcare services company. The Company's segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. The Company owns and operates approximately 524 centers in 39 states and the District of Columbia. The Company's Home Health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The Hospice segment provides support for those who are dealing with a terminal illness, such as heart disease, pulmonary disease, Alzheimer's and Human Immunodeficiency Virus (HIV)/Acquired Immuno Deficiency Syndrome (AIDS). The Personal care segment provides patients with assistance with the essential activities of daily living.

Webull offers kinds of Amedisys Inc stock information, including NASDAQ:AMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMED stock methods without spending real money on the virtual paper trading platform.